CTHRepealedLegislation
National Health (Botulinum Toxin Program) Special Arrangement 2011 (No. PB 89 of 2011)
//
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
National Health (Botulinum Toxin Program) Special Arrangement 2011 (No. PB 89 of 2011)
Start here
Turn the raw legal text into a practical explanation grounded in National Health (Botulinum Toxin Program) Special Arrangement 2011 (No. PB 89 of 2011).
(1) If the Chief Executive Medicare issues an eligible medical practitioner with a new or additional provider number, under which the eligible medical practitioner intends to administer botulinum toxin pharmaceutical benefits under this Special Arrangement, the eligible medical practitioner, or a person authorised under section 15, must notify the Chief Executive Medicare of the new or additional provider number. (2) The Chief Executive Medicare must not place an order for supply of a botulinum toxin pharmaceutical benefit under this Special Arrangement with a responsible person for a provider number that has been changed unless the Chief Executive Medicare has previously been told of the new provider number, under subsection (1).